001     281887
005     20240625095121.0
024 7 _ |a 10.1371/journal.pone.0134506
|2 doi
024 7 _ |a 2128/9847
|2 Handle
024 7 _ |a WOS:000358836800146
|2 WOS
024 7 _ |a altmetric:4342359
|2 altmetric
024 7 _ |a pmid:26222439
|2 pmid
037 _ _ |a FZJ-2016-01549
082 _ _ |a 500
100 1 _ |a Giménez-Dejoz, Joan
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase
260 _ _ |a Lawrence, Kan.
|c 2015
|b PLoS
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1455006168_7284
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Human aldo-keto reductase 1B15 (AKR1B15) is a newly discovered enzyme which shares 92% amino acid sequence identity with AKR1B10. While AKR1B10 is a well characterized enzyme with high retinaldehyde reductase activity, involved in the development of several cancer types, the enzymatic activity and physiological role of AKR1B15 are still poorly known. Here, the purified recombinant enzyme has been subjected to substrate specificity characterization, kinetic analysis and inhibitor screening, combined with structural modeling. AKR1B15 is active towards a variety of carbonyl substrates, including retinoids, with lower kcat and Km values than AKR1B10. In contrast to AKR1B10, which strongly prefers all-trans-retinaldehyde, AKR1B15 exhibits superior catalytic efficiency with 9-cis-retinaldehyde, the best substrate found for this enzyme. With ketone and dicarbonyl substrates, AKR1B15 also shows higher catalytic activity than AKR1B10. Several typical AKR inhibitors do not significantly affect AKR1B15 activity. Amino acid substitutions clustered in loops A and C result in a smaller, more hydrophobic and more rigid active site in AKR1B15 compared with the AKR1B10 pocket, consistent with distinct substrate specificity and narrower inhibitor selectivity for AKR1B15.
536 _ _ |a 574 - Theory, modelling and simulation (POF3-574)
|0 G:(DE-HGF)POF3-574
|c POF3-574
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kolář, Michal H.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Ruiz, Francesc X.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Crespo, Isidro
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Cousido-Siah, Alexandra
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Podjarny, Alberto
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Barski, Oleg A.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fanfrlík, Jindřich
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Parés, Xavier
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Farrés, Jaume
|0 P:(DE-HGF)0
|b 9
|e Corresponding author
700 1 _ |a Porté, Sergio
|0 P:(DE-HGF)0
|b 10
|e Corresponding author
773 _ _ |a 10.1371/journal.pone.0134506
|g Vol. 10, no. 7, p. e0134506 -
|0 PERI:(DE-600)2267670-3
|n 7
|p e0134506 -
|t PLoS one
|v 10
|y 2015
|x 1932-6203
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.jpg?subformat=icon-640
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/281887/files/journal.pone.0134506.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:281887
|p openaire
|p open_access
|p driver
|p VDB
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-574
|2 G:(DE-HGF)POF3-500
|v Theory, modelling and simulation
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PLOS ONE : 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-9-20140121
|k INM-9
|l Computational Biomedicine
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-9-20140121
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 1 _ |a UNRESTRICTED
980 1 _ |a FullTexts
981 _ _ |a I:(DE-Juel1)IAS-5-20120330


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21